Tonix Pharm Holdings (TNXP)

Apr 2, 2025, 7:00 AM EDT - 22 hours ago

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

Apr 1, 2025, 7:00 AM EDT - 1 day ago

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

Mar 31, 2025, 7:00 AM EDT - 2 days ago

Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

Mar 27, 2025, 7:00 AM EDT - 6 days ago

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

Mar 26, 2025, 2:30 AM EDT - 8 days ago

Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years

Mar 25, 2025, 8:16 AM EDT - 8 days ago

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

ARQT

Mar 24, 2025, 8:00 AM EDT - 9 days ago

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

Mar 20, 2025, 7:00 AM EDT - 13 days ago

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals' Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

Mar 19, 2025, 8:15 AM EDT - 14 days ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

ABSI HQY

Mar 18, 2025, 4:30 PM EDT - 15 days ago

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 13, 2025, 7:00 AM EDT - 20 days ago

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

Mar 12, 2025, 7:30 AM EDT - 21 days ago

Tonix's TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

Mar 11, 2025, 7:00 AM EDT - 22 days ago

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

Mar 10, 2025, 8:00 AM EDT - 23 days ago

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company's Single-Dose Mpox and Smallpox Vaccine Candidate

Mar 5, 2025, 7:00 AM EST - 4 weeks ago

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

Mar 4, 2025, 7:00 AM EST - 4 weeks ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

Feb 7, 2025, 8:30 AM EST - 7 weeks ago

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Feb 6, 2025, 8:00 AM EST - 7 weeks ago

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

Feb 5, 2025, 7:00 AM EST - 2 months ago

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference

Feb 4, 2025, 7:00 AM EST - 2 months ago

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer

Feb 3, 2025, 8:05 AM EST - 2 months ago

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Dec 23, 2024, 8:00 AM EST - 3 months ago

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Dec 17, 2024, 10:59 AM EST - 3 months ago

FDA accepts Tonix's NDA for non-opioid fibromyalgia drug TNX-102 SL

Dec 17, 2024, 8:00 AM EST - 3 months ago

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Dec 16, 2024, 11:40 AM EST - 3 months ago

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

Dec 9, 2024, 7:30 AM EST - 4 months ago

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

Nov 26, 2024, 7:00 AM EST - 4 months ago

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Nov 21, 2024, 4:27 AM EST - 4 months ago

Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed

Nov 18, 2024, 4:05 PM EST - 4 months ago

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Nov 14, 2024, 7:30 AM EST - 4 months ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Nov 13, 2024, 4:05 PM EST - 5 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Nov 13, 2024, 9:05 AM EST - 5 months ago

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

Nov 1, 2024, 7:00 AM EDT - 5 months ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

Oct 29, 2024, 8:00 AM EDT - 5 months ago

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

Oct 25, 2024, 8:00 AM EDT - 5 months ago

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Oct 16, 2024, 8:00 AM EDT - 6 months ago

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

Oct 8, 2024, 8:30 AM EDT - 6 months ago

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

Oct 1, 2024, 7:30 AM EDT - 6 months ago

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

Sep 27, 2024, 7:00 AM EDT - 6 months ago

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines

Sep 19, 2024, 7:00 AM EDT - 6 months ago

Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines

Sep 18, 2024, 7:30 AM EDT - 7 months ago

New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution

Sep 16, 2024, 7:00 AM EDT - 7 months ago

Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO's Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency

Sep 10, 2024, 4:01 AM EDT - 7 months ago

Penny stocks analysis: AITX, Intelligent Bio (INBS), Tonix (TNXP)

INBS

Sep 6, 2024, 7:00 AM EDT - 7 months ago

Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek

Sep 4, 2024, 7:00 AM EDT - 7 months ago

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

Aug 29, 2024, 7:00 AM EDT - 7 months ago

Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)

Aug 26, 2024, 10:41 AM EDT - 7 months ago

Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine

Aug 26, 2024, 7:00 AM EDT - 7 months ago

Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix's Mpox Vaccine, TNX-801

Aug 23, 2024, 7:45 AM EDT - 7 months ago

Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency

Aug 19, 2024, 6:00 AM EDT - 8 months ago

Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights